Cimetropium bromide is discontinued (DEA controlled substance). Cimetropium bromide is an antimuscarinic compound with strong antispasmodic activity. Cimetropium bromide has been shown to shorten whole gut transit time in IBS patients with prolonged transit time. References: Passaretti S, Guslandi M, Imbimbo BP, Daniotti S, Tittobello A. Effects of cimetropium bromide on gastrointestinal transit time in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 1989 Jun;3(3):267-76. PubMed PMID: 2520622.

纯度：≥98%

CAS：51598-60-8